Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy in Diabetics | 18 | 2023 | 179 | 2.140 |
Why?
|
Drug Labeling | 3 | 2017 | 233 | 1.420 |
Why?
|
Drug Approval | 6 | 2020 | 742 | 1.300 |
Why?
|
Pregnancy | 108 | 2023 | 29144 | 1.140 |
Why?
|
Informed Consent | 4 | 2020 | 995 | 1.140 |
Why?
|
Fetal Diseases | 20 | 2016 | 903 | 1.130 |
Why?
|
Pregnancy Outcome | 18 | 2022 | 2795 | 1.070 |
Why?
|
United States Food and Drug Administration | 9 | 2020 | 1584 | 1.060 |
Why?
|
Pregnancy Complications | 11 | 2022 | 2861 | 1.000 |
Why?
|
Trisomy | 4 | 2014 | 266 | 0.970 |
Why?
|
Diabetes, Gestational | 6 | 2023 | 1184 | 0.920 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2022 | 489 | 0.900 |
Why?
|
Prenatal Diagnosis | 15 | 2014 | 1236 | 0.870 |
Why?
|
Abortifacient Agents, Steroidal | 2 | 2016 | 19 | 0.830 |
Why?
|
Labor, Induced | 3 | 2018 | 146 | 0.790 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2015 | 367 | 0.790 |
Why?
|
Cesarean Section | 11 | 2017 | 1365 | 0.780 |
Why?
|
Mifepristone | 2 | 2016 | 150 | 0.770 |
Why?
|
Abortion, Spontaneous | 5 | 2019 | 544 | 0.730 |
Why?
|
Contraception, Postcoital | 2 | 2011 | 22 | 0.720 |
Why?
|
Abortion, Threatened | 1 | 2019 | 4 | 0.700 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2047 | 0.680 |
Why?
|
Abortion, Legal | 4 | 2015 | 116 | 0.670 |
Why?
|
Progestins | 1 | 2020 | 306 | 0.650 |
Why?
|
Pregnancy Complications, Neoplastic | 3 | 2017 | 255 | 0.640 |
Why?
|
Choice Behavior | 2 | 2018 | 802 | 0.630 |
Why?
|
Perinatal Mortality | 2 | 2015 | 105 | 0.600 |
Why?
|
Cesarean Section, Repeat | 2 | 2009 | 29 | 0.590 |
Why?
|
Congenital Abnormalities | 9 | 2010 | 707 | 0.580 |
Why?
|
Delivery, Obstetric | 4 | 2021 | 906 | 0.530 |
Why?
|
Home Childbirth | 1 | 2015 | 51 | 0.520 |
Why?
|
Pre-Eclampsia | 5 | 2017 | 1200 | 0.520 |
Why?
|
Anesthetics, General | 1 | 2017 | 152 | 0.510 |
Why?
|
Physical Examination | 3 | 2020 | 1237 | 0.510 |
Why?
|
Chromosome Disorders | 5 | 2013 | 514 | 0.490 |
Why?
|
Government Regulation | 2 | 2016 | 522 | 0.480 |
Why?
|
Anesthesia, General | 3 | 2020 | 1171 | 0.470 |
Why?
|
Ribavirin | 4 | 2022 | 395 | 0.470 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2017 | 2408 | 0.460 |
Why?
|
Hyperglycemia | 1 | 2022 | 1373 | 0.460 |
Why?
|
Retinopathy of Prematurity | 2 | 2015 | 421 | 0.450 |
Why?
|
Lactation | 1 | 2015 | 412 | 0.440 |
Why?
|
Uterine Rupture | 2 | 2004 | 72 | 0.440 |
Why?
|
Vaginal Birth after Cesarean | 2 | 2004 | 62 | 0.430 |
Why?
|
Oxygen | 2 | 2015 | 4189 | 0.430 |
Why?
|
Human Experimentation | 1 | 2013 | 127 | 0.420 |
Why?
|
Obstetrics | 3 | 2017 | 658 | 0.420 |
Why?
|
Blood Glucose | 8 | 2022 | 6254 | 0.410 |
Why?
|
Abnormalities, Drug-Induced | 3 | 2014 | 317 | 0.400 |
Why?
|
Diethylstilbestrol | 1 | 2011 | 93 | 0.390 |
Why?
|
Midwifery | 1 | 2012 | 132 | 0.390 |
Why?
|
Pregnant Women | 1 | 2015 | 568 | 0.370 |
Why?
|
Nonprescription Drugs | 3 | 2008 | 116 | 0.370 |
Why?
|
Female | 116 | 2023 | 380193 | 0.370 |
Why?
|
Vaginal Neoplasms | 1 | 2011 | 106 | 0.370 |
Why?
|
Fetus | 6 | 2014 | 1880 | 0.360 |
Why?
|
Fetal Therapies | 1 | 2011 | 100 | 0.360 |
Why?
|
Infant, Premature, Diseases | 2 | 2015 | 707 | 0.360 |
Why?
|
Meningomyelocele | 2 | 2011 | 165 | 0.350 |
Why?
|
Premature Birth | 2 | 2020 | 1721 | 0.350 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2011 | 221 | 0.350 |
Why?
|
Drug Industry | 1 | 2015 | 746 | 0.340 |
Why?
|
Anesthesia | 1 | 2020 | 1561 | 0.340 |
Why?
|
Contraceptives, Postcoital | 2 | 2005 | 16 | 0.330 |
Why?
|
Education, Medical | 1 | 2020 | 1722 | 0.320 |
Why?
|
Prescription Drugs | 1 | 2015 | 595 | 0.320 |
Why?
|
Radiotherapy | 1 | 2015 | 1533 | 0.320 |
Why?
|
Contraceptives, Oral, Synthetic | 1 | 2008 | 16 | 0.320 |
Why?
|
Endocrine Disruptors | 1 | 2011 | 237 | 0.310 |
Why?
|
Politics | 3 | 2011 | 791 | 0.310 |
Why?
|
Levonorgestrel | 1 | 2008 | 77 | 0.300 |
Why?
|
Fetal Blood | 11 | 2008 | 1318 | 0.290 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2000 | 3338 | 0.290 |
Why?
|
Women's Rights | 1 | 2007 | 69 | 0.290 |
Why?
|
Asphyxia | 1 | 2006 | 57 | 0.280 |
Why?
|
SAIDS Vaccines | 3 | 1999 | 166 | 0.280 |
Why?
|
Humans | 122 | 2023 | 744366 | 0.280 |
Why?
|
Clostridium sordellii | 1 | 2005 | 3 | 0.280 |
Why?
|
Legislation, Drug | 1 | 2008 | 206 | 0.270 |
Why?
|
Supreme Court Decisions | 1 | 2007 | 128 | 0.270 |
Why?
|
Down Syndrome | 1 | 2014 | 880 | 0.270 |
Why?
|
Obstetric Labor, Premature | 3 | 2003 | 279 | 0.260 |
Why?
|
Personal Autonomy | 1 | 2008 | 298 | 0.260 |
Why?
|
Aspirin | 1 | 2017 | 3283 | 0.260 |
Why?
|
Labor, Obstetric | 3 | 2001 | 333 | 0.260 |
Why?
|
Pregnancy Trimester, First | 5 | 2023 | 853 | 0.250 |
Why?
|
Abortion, Therapeutic | 1 | 2004 | 35 | 0.240 |
Why?
|
Hypoglycemic Agents | 3 | 2008 | 2873 | 0.240 |
Why?
|
United States | 25 | 2021 | 69872 | 0.240 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7914 | 0.240 |
Why?
|
Fetal Death | 5 | 2009 | 448 | 0.240 |
Why?
|
Child Development | 1 | 2015 | 2223 | 0.230 |
Why?
|
Progesterone Congeners | 1 | 2003 | 42 | 0.230 |
Why?
|
Abortion, Induced | 3 | 2008 | 458 | 0.230 |
Why?
|
Hydroxyprogesterones | 1 | 2003 | 25 | 0.230 |
Why?
|
Oximetry | 1 | 2006 | 471 | 0.220 |
Why?
|
DNA | 3 | 2013 | 7294 | 0.220 |
Why?
|
Teratogens | 3 | 2022 | 112 | 0.220 |
Why?
|
Magnesium Sulfate | 1 | 2003 | 68 | 0.220 |
Why?
|
Insulin | 7 | 2008 | 6582 | 0.210 |
Why?
|
Amniotic Fluid | 6 | 2000 | 370 | 0.210 |
Why?
|
Genetic Testing | 2 | 2014 | 3444 | 0.210 |
Why?
|
Breech Presentation | 1 | 2002 | 44 | 0.210 |
Why?
|
Heart | 1 | 2015 | 4464 | 0.210 |
Why?
|
Private Sector | 1 | 2005 | 392 | 0.210 |
Why?
|
Respiratory Distress Syndrome, Newborn | 3 | 2009 | 214 | 0.200 |
Why?
|
Infant, Newborn | 29 | 2017 | 25628 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3595 | 0.200 |
Why?
|
Pregnancy Trimester, Second | 2 | 2023 | 732 | 0.200 |
Why?
|
Microcephaly | 2 | 2016 | 432 | 0.190 |
Why?
|
Metformin | 1 | 2008 | 836 | 0.190 |
Why?
|
Hypoglycemia | 1 | 2008 | 861 | 0.190 |
Why?
|
Gynecological Examination | 1 | 2020 | 33 | 0.190 |
Why?
|
Glyburide | 1 | 2000 | 113 | 0.180 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2021 | 2026 | 0.180 |
Why?
|
Biological Specimen Banks | 1 | 2005 | 711 | 0.180 |
Why?
|
Parathyroid Neoplasms | 2 | 2011 | 245 | 0.180 |
Why?
|
Fetal Organ Maturity | 5 | 2009 | 82 | 0.180 |
Why?
|
Pulmonary Surfactants | 2 | 2000 | 162 | 0.170 |
Why?
|
alpha-Fetoproteins | 2 | 1991 | 224 | 0.170 |
Why?
|
Health Policy | 1 | 2011 | 2661 | 0.170 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2002 | 407 | 0.170 |
Why?
|
Clostridium Infections | 1 | 2005 | 548 | 0.170 |
Why?
|
Neural Crest | 1 | 2001 | 275 | 0.160 |
Why?
|
Phosphatidylcholines | 2 | 2000 | 411 | 0.160 |
Why?
|
Gestational Age | 17 | 2009 | 3493 | 0.160 |
Why?
|
Women's Health | 1 | 2008 | 2034 | 0.160 |
Why?
|
Cognition | 1 | 2015 | 6770 | 0.160 |
Why?
|
Infant, Premature | 4 | 2002 | 2045 | 0.150 |
Why?
|
Hospitalization | 2 | 2021 | 10259 | 0.150 |
Why?
|
History, 20th Century | 3 | 2012 | 2740 | 0.150 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2017 | 68 | 0.150 |
Why?
|
Anencephaly | 2 | 2007 | 20 | 0.140 |
Why?
|
Gynecology | 1 | 2002 | 513 | 0.140 |
Why?
|
Intelligence | 1 | 2002 | 920 | 0.140 |
Why?
|
Needs Assessment | 1 | 2002 | 1147 | 0.140 |
Why?
|
Simian immunodeficiency virus | 4 | 1999 | 846 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 9955 | 0.140 |
Why?
|
Decidua | 1 | 1996 | 86 | 0.140 |
Why?
|
Voluntary Health Agencies | 1 | 2015 | 39 | 0.130 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2017 | 109 | 0.130 |
Why?
|
Drug Information Services | 1 | 2015 | 51 | 0.130 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 1996 | 233 | 0.130 |
Why?
|
Fetal Macrosomia | 3 | 2005 | 124 | 0.130 |
Why?
|
Embryo Research | 1 | 2015 | 60 | 0.130 |
Why?
|
Mass Screening | 2 | 2023 | 5253 | 0.130 |
Why?
|
Placenta, Retained | 1 | 2014 | 21 | 0.120 |
Why?
|
Uterine Inertia | 1 | 2014 | 29 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 775 | 0.120 |
Why?
|
Brain | 3 | 2017 | 26388 | 0.120 |
Why?
|
Pancreatitis | 2 | 2011 | 1092 | 0.120 |
Why?
|
Risk | 5 | 2013 | 9688 | 0.120 |
Why?
|
Pregnancy, Multiple | 3 | 1994 | 217 | 0.120 |
Why?
|
Ultrasonography | 12 | 1989 | 5984 | 0.120 |
Why?
|
Therapeutic Equipoise | 1 | 2013 | 28 | 0.110 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2014 | 245 | 0.110 |
Why?
|
Physician-Patient Relations | 3 | 2020 | 3229 | 0.110 |
Why?
|
State Government | 1 | 2016 | 372 | 0.110 |
Why?
|
Placenta | 1 | 2022 | 1699 | 0.110 |
Why?
|
Anticonvulsants | 1 | 2003 | 1916 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 4 | 2001 | 1695 | 0.110 |
Why?
|
Vaccines, Attenuated | 4 | 1999 | 342 | 0.110 |
Why?
|
Physicians | 2 | 2008 | 4567 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13693 | 0.100 |
Why?
|
Vaccines | 1 | 2021 | 823 | 0.100 |
Why?
|
Uterus | 1 | 1996 | 711 | 0.100 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 5 | 1999 | 570 | 0.100 |
Why?
|
Hypercalcemia | 2 | 2011 | 409 | 0.100 |
Why?
|
Risk Factors | 11 | 2020 | 72296 | 0.100 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1999 | 1320 | 0.100 |
Why?
|
AIDS Vaccines | 2 | 1995 | 938 | 0.100 |
Why?
|
Hysterectomy | 1 | 2017 | 927 | 0.100 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2015 | 430 | 0.100 |
Why?
|
Placenta Previa | 1 | 2012 | 117 | 0.100 |
Why?
|
Postpartum Hemorrhage | 1 | 2014 | 258 | 0.090 |
Why?
|
Menotropins | 1 | 1990 | 45 | 0.090 |
Why?
|
Adenoma | 2 | 2011 | 2174 | 0.090 |
Why?
|
Mullerian Ducts | 1 | 2011 | 198 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 693 | 0.090 |
Why?
|
History, 19th Century | 1 | 2012 | 720 | 0.090 |
Why?
|
Fetal Monitoring | 2 | 2006 | 70 | 0.090 |
Why?
|
Hyperparathyroidism | 1 | 2011 | 339 | 0.090 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 426 | 0.090 |
Why?
|
Time | 1 | 2011 | 542 | 0.090 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 160 | 0.090 |
Why?
|
Vasculitis | 1 | 2013 | 519 | 0.080 |
Why?
|
Infant Mortality | 3 | 2004 | 754 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1796 | 0.080 |
Why?
|
Lung | 4 | 2009 | 9857 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2647 | 0.080 |
Why?
|
Health Services Accessibility | 1 | 2005 | 5135 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1677 | 0.080 |
Why?
|
Civil Rights | 1 | 2008 | 132 | 0.080 |
Why?
|
Chromosomes, Human, 13-15 | 2 | 1986 | 52 | 0.080 |
Why?
|
Hemorrhage | 2 | 2019 | 3461 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2015 | 3922 | 0.070 |
Why?
|
Blood Banks | 1 | 2008 | 111 | 0.070 |
Why?
|
Chronic Disease | 2 | 2002 | 9145 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2002 | 4369 | 0.070 |
Why?
|
Breast Feeding | 1 | 2015 | 1338 | 0.070 |
Why?
|
Ovulation | 1 | 2008 | 189 | 0.070 |
Why?
|
Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 1996 | 1540 | 0.070 |
Why?
|
Heart Rate, Fetal | 1 | 2006 | 75 | 0.070 |
Why?
|
History, 21st Century | 1 | 2012 | 1534 | 0.070 |
Why?
|
Paternal Exposure | 1 | 2007 | 89 | 0.070 |
Why?
|
Hernia, Umbilical | 1 | 2007 | 96 | 0.070 |
Why?
|
Hydranencephaly | 1 | 1985 | 5 | 0.070 |
Why?
|
Adult | 31 | 2021 | 214052 | 0.070 |
Why?
|
Globins | 4 | 1988 | 416 | 0.070 |
Why?
|
Adrenocortical Carcinoma | 1 | 2006 | 88 | 0.070 |
Why?
|
Vagina | 1 | 2011 | 825 | 0.070 |
Why?
|
Blood Donors | 1 | 2008 | 355 | 0.070 |
Why?
|
Fetal Development | 1 | 2011 | 767 | 0.060 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2008 | 314 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2017 | 2987 | 0.060 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2006 | 162 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2020 | 0.060 |
Why?
|
Cushing Syndrome | 1 | 2006 | 249 | 0.060 |
Why?
|
Morals | 1 | 2008 | 285 | 0.060 |
Why?
|
Pregnancy Complications, Cardiovascular | 3 | 1997 | 500 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3070 | 0.060 |
Why?
|
Trial of Labor | 1 | 2004 | 80 | 0.060 |
Why?
|
Macaca | 2 | 1996 | 440 | 0.060 |
Why?
|
Autoimmune Diseases | 2 | 2013 | 2134 | 0.060 |
Why?
|
Calcium | 1 | 1997 | 5755 | 0.060 |
Why?
|
Chromosome Aberrations | 3 | 1988 | 1813 | 0.060 |
Why?
|
Oligohydramnios | 2 | 2001 | 35 | 0.060 |
Why?
|
Rh Isoimmunization | 2 | 2017 | 21 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4216 | 0.060 |
Why?
|
Cryopreservation | 1 | 2008 | 670 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 2013 | 4153 | 0.060 |
Why?
|
History, 17th Century | 1 | 2003 | 111 | 0.050 |
Why?
|
Craniosynostoses | 1 | 2007 | 401 | 0.050 |
Why?
|
Maternal Mortality | 1 | 2005 | 310 | 0.050 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 1983 | 102 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2007 | 895 | 0.050 |
Why?
|
Eclampsia | 1 | 2003 | 58 | 0.050 |
Why?
|
Nifedipine | 1 | 2003 | 227 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 7730 | 0.050 |
Why?
|
Opioid-Related Disorders | 1 | 2017 | 2064 | 0.050 |
Why?
|
History, 18th Century | 1 | 2003 | 213 | 0.050 |
Why?
|
Neoplasms, Fibroepithelial | 1 | 2001 | 8 | 0.050 |
Why?
|
Cerebral Palsy | 1 | 2006 | 459 | 0.050 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1983 | 183 | 0.050 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 1982 | 189 | 0.050 |
Why?
|
Animals, Newborn | 3 | 1996 | 2726 | 0.050 |
Why?
|
Registries | 2 | 2022 | 8091 | 0.050 |
Why?
|
Thrombophlebitis | 2 | 1996 | 309 | 0.050 |
Why?
|
Infant | 3 | 2022 | 35134 | 0.050 |
Why?
|
Prostaglandins | 1 | 2001 | 405 | 0.050 |
Why?
|
Hydrocephalus | 2 | 1986 | 748 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2005 | 2124 | 0.040 |
Why?
|
Safety | 2 | 2014 | 1186 | 0.040 |
Why?
|
Blood Transfusion, Intrauterine | 3 | 1988 | 26 | 0.040 |
Why?
|
Sepsis | 2 | 2009 | 2593 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4933 | 0.040 |
Why?
|
Albumins | 3 | 2000 | 568 | 0.040 |
Why?
|
Kidney Tubules | 1 | 2001 | 488 | 0.040 |
Why?
|
Sulfonylurea Compounds | 1 | 2000 | 205 | 0.040 |
Why?
|
Erythroblastosis, Fetal | 3 | 1988 | 60 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2003 | 976 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 2008 | 1637 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2008 | 2055 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2013 | 14723 | 0.040 |
Why?
|
Staining and Labeling | 2 | 1992 | 1101 | 0.040 |
Why?
|
Urinary Bladder | 3 | 1993 | 1173 | 0.040 |
Why?
|
Gene Deletion | 2 | 1996 | 2751 | 0.040 |
Why?
|
Adolescent | 7 | 2017 | 85779 | 0.040 |
Why?
|
Heart Transplantation | 1 | 1991 | 3112 | 0.040 |
Why?
|
Salpingectomy | 1 | 2017 | 53 | 0.040 |
Why?
|
Child, Preschool | 3 | 2017 | 41005 | 0.040 |
Why?
|
Research | 1 | 2005 | 1999 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2001 | 2327 | 0.040 |
Why?
|
Genes, vpr | 1 | 1996 | 20 | 0.040 |
Why?
|
Endometritis | 1 | 1996 | 48 | 0.040 |
Why?
|
Glucose Tolerance Test | 2 | 1997 | 1151 | 0.030 |
Why?
|
Genes, nef | 1 | 1996 | 55 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2005 | 1620 | 0.030 |
Why?
|
Risk-Taking | 1 | 2002 | 986 | 0.030 |
Why?
|
Hypertension | 3 | 2006 | 8479 | 0.030 |
Why?
|
Trust | 1 | 2020 | 505 | 0.030 |
Why?
|
Blood Specimen Collection | 2 | 1988 | 246 | 0.030 |
Why?
|
Retroviruses, Simian | 1 | 1995 | 12 | 0.030 |
Why?
|
Chorionic Villi | 1 | 1995 | 51 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.030 |
Why?
|
Abortion, Habitual | 1 | 1995 | 70 | 0.030 |
Why?
|
Genetic Counseling | 1 | 1999 | 600 | 0.030 |
Why?
|
Forecasting | 2 | 2002 | 2951 | 0.030 |
Why?
|
Incidence | 4 | 2001 | 20952 | 0.030 |
Why?
|
HIV Infections | 2 | 1999 | 16715 | 0.030 |
Why?
|
Ovariectomy | 1 | 2017 | 661 | 0.030 |
Why?
|
Reproductive Techniques | 1 | 1994 | 42 | 0.030 |
Why?
|
Male | 18 | 2022 | 350115 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 2 | 2011 | 571 | 0.030 |
Why?
|
Triplets | 2 | 1994 | 43 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2017 | 469 | 0.030 |
Why?
|
Educational Status | 1 | 2002 | 2540 | 0.030 |
Why?
|
Child of Impaired Parents | 1 | 2017 | 455 | 0.030 |
Why?
|
Heart Defects, Congenital | 2 | 2007 | 4583 | 0.030 |
Why?
|
Placenta Diseases | 1 | 1995 | 199 | 0.030 |
Why?
|
Genes | 2 | 1987 | 1893 | 0.030 |
Why?
|
Ectromelia | 1 | 1993 | 31 | 0.030 |
Why?
|
Hematoxylin | 1 | 1992 | 64 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1992 | 72 | 0.030 |
Why?
|
Urethral Obstruction | 2 | 1993 | 56 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2011 | 63107 | 0.030 |
Why?
|
Low Back Pain | 2 | 2011 | 956 | 0.030 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1992 | 81 | 0.030 |
Why?
|
Respiration Disorders | 1 | 1996 | 371 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 1996 | 1423 | 0.030 |
Why?
|
Hospital Charges | 1 | 1994 | 362 | 0.030 |
Why?
|
Animals | 11 | 2022 | 168768 | 0.030 |
Why?
|
Edema | 2 | 1986 | 789 | 0.030 |
Why?
|
Anthropometry | 2 | 1995 | 1350 | 0.030 |
Why?
|
Microcirculation | 1 | 1996 | 1287 | 0.030 |
Why?
|
Sweden | 1 | 2014 | 1341 | 0.020 |
Why?
|
Virulence | 1 | 1995 | 1333 | 0.020 |
Why?
|
Arteries | 1 | 1996 | 1119 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 1992 | 186 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 456 | 0.020 |
Why?
|
Reference Standards | 1 | 1995 | 1025 | 0.020 |
Why?
|
Quadruplets | 1 | 1990 | 9 | 0.020 |
Why?
|
Abnormalities, Multiple | 2 | 2001 | 1416 | 0.020 |
Why?
|
Clomiphene | 1 | 1990 | 72 | 0.020 |
Why?
|
Virus Replication | 2 | 1995 | 2535 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1999 | 1178 | 0.020 |
Why?
|
Abdominal Muscles | 1 | 1991 | 166 | 0.020 |
Why?
|
Glucose Intolerance | 1 | 1994 | 577 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8300 | 0.020 |
Why?
|
Polyhydramnios | 1 | 1989 | 41 | 0.020 |
Why?
|
Coloring Agents | 1 | 1972 | 566 | 0.020 |
Why?
|
South Dakota | 1 | 2008 | 30 | 0.020 |
Why?
|
Head | 1 | 1995 | 880 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2013 | 77460 | 0.020 |
Why?
|
Autopsy | 1 | 1992 | 1020 | 0.020 |
Why?
|
Reference Values | 1 | 1996 | 4982 | 0.020 |
Why?
|
Models, Biological | 2 | 1996 | 9584 | 0.020 |
Why?
|
Amniocentesis | 1 | 1988 | 116 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2001 | 2249 | 0.020 |
Why?
|
Reproductive Rights | 1 | 2008 | 35 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2011 | 15297 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 1999 | 2278 | 0.020 |
Why?
|
Age Factors | 1 | 2005 | 18373 | 0.020 |
Why?
|
Puerperal Disorders | 1 | 1991 | 275 | 0.020 |
Why?
|
Urologic Diseases | 1 | 1991 | 244 | 0.020 |
Why?
|
Noonan Syndrome | 1 | 1989 | 122 | 0.020 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1989 | 140 | 0.020 |
Why?
|
Vomiting | 1 | 2011 | 637 | 0.020 |
Why?
|
Infertility, Female | 1 | 1994 | 788 | 0.020 |
Why?
|
Fetal Hemoglobin | 2 | 1988 | 341 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 738 | 0.020 |
Why?
|
Gene Products, vpr | 2 | 1999 | 36 | 0.020 |
Why?
|
Fetal Distress | 1 | 1987 | 40 | 0.020 |
Why?
|
Gene Products, nef | 2 | 1999 | 110 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5316 | 0.020 |
Why?
|
Butyrates | 1 | 1987 | 163 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Birth Weight | 1 | 1995 | 2069 | 0.020 |
Why?
|
Gigantism | 1 | 1986 | 15 | 0.020 |
Why?
|
Observer Variation | 1 | 1992 | 2593 | 0.020 |
Why?
|
Maternal Age | 1 | 1989 | 802 | 0.020 |
Why?
|
Rats | 2 | 2001 | 24252 | 0.020 |
Why?
|
Charities | 1 | 2005 | 31 | 0.020 |
Why?
|
Polycythemia | 1 | 1986 | 126 | 0.020 |
Why?
|
Twins, Conjoined | 1 | 1985 | 41 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2011 | 12961 | 0.020 |
Why?
|
Macaca mulatta | 3 | 1999 | 2377 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
Maternal Welfare | 1 | 2005 | 115 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 1986 | 250 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2011 | 1064 | 0.020 |
Why?
|
Europe | 1 | 1991 | 3338 | 0.020 |
Why?
|
Young Adult | 3 | 2017 | 56429 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1991 | 1782 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 5953 | 0.010 |
Why?
|
Neural Tube Defects | 1 | 1986 | 256 | 0.010 |
Why?
|
Speech | 1 | 2008 | 541 | 0.010 |
Why?
|
Needles | 1 | 1986 | 449 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1992 | 2969 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1986 | 544 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15535 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11031 | 0.010 |
Why?
|
Fertilization in Vitro | 1 | 1990 | 1284 | 0.010 |
Why?
|
Karyotyping | 3 | 1989 | 1243 | 0.010 |
Why?
|
Ultrasonics | 1 | 1982 | 212 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 1986 | 608 | 0.010 |
Why?
|
Amnion | 1 | 1982 | 209 | 0.010 |
Why?
|
Time Factors | 3 | 1992 | 40075 | 0.010 |
Why?
|
Risk Assessment | 2 | 2007 | 23336 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 1994 | 15078 | 0.010 |
Why?
|
Polyps | 1 | 2001 | 189 | 0.010 |
Why?
|
Aging | 1 | 1999 | 8664 | 0.010 |
Why?
|
Prognosis | 3 | 2017 | 29060 | 0.010 |
Why?
|
Prospective Studies | 3 | 1995 | 53290 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13409 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 1991 | 1912 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2006 | 1826 | 0.010 |
Why?
|
Molecular Sequence Data | 3 | 1999 | 18111 | 0.010 |
Why?
|
Heparin | 1 | 1985 | 1637 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1985 | 1151 | 0.010 |
Why?
|
Erythrocytes | 1 | 1987 | 2455 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 1993 | 18034 | 0.010 |
Why?
|
Emergencies | 1 | 2004 | 1170 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15221 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6621 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7184 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7282 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1986 | 1848 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 6489 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2001 | 1851 | 0.010 |
Why?
|
Child | 2 | 2017 | 77709 | 0.010 |
Why?
|
Diabetes Mellitus | 3 | 1989 | 5749 | 0.010 |
Why?
|
Societies, Medical | 1 | 2008 | 3743 | 0.010 |
Why?
|
HIV-1 | 1 | 1993 | 6939 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 1999 | 490 | 0.010 |
Why?
|
Methylation | 2 | 1988 | 1106 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1999 | 1525 | 0.010 |
Why?
|
Surface-Active Agents | 1 | 1994 | 159 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1995 | 294 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1986 | 3390 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1999 | 792 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 1999 | 737 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1987 | 7721 | 0.010 |
Why?
|
Retroviridae Infections | 1 | 1993 | 151 | 0.010 |
Why?
|
Disclosure | 1 | 1999 | 736 | 0.010 |
Why?
|
Fibrin | 1 | 1995 | 506 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 1985 | 2375 | 0.010 |
Why?
|
Twins | 1 | 1994 | 339 | 0.010 |
Why?
|
Echocardiography | 1 | 1985 | 5099 | 0.010 |
Why?
|
Base Sequence | 2 | 1995 | 12797 | 0.010 |
Why?
|
Microtomy | 1 | 1972 | 47 | 0.010 |
Why?
|
Gene Products, gag | 1 | 1993 | 337 | 0.010 |
Why?
|
Methods | 1 | 1972 | 1129 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 40559 | 0.010 |
Why?
|
Suction | 1 | 1992 | 267 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1995 | 673 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1995 | 794 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4253 | 0.010 |
Why?
|
Urinary Diversion | 1 | 1991 | 138 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6459 | 0.010 |
Why?
|
Succinylcholine | 1 | 1989 | 67 | 0.010 |
Why?
|
Lymphangioma | 1 | 1989 | 65 | 0.010 |
Why?
|
Anesthesia, Intravenous | 1 | 1989 | 130 | 0.000 |
Why?
|
Blood Grouping and Crossmatching | 1 | 1988 | 108 | 0.000 |
Why?
|
Hydrops Fetalis | 1 | 1988 | 107 | 0.000 |
Why?
|
Chorioamnionitis | 1 | 1989 | 155 | 0.000 |
Why?
|
Anesthesia, Inhalation | 1 | 1989 | 222 | 0.000 |
Why?
|
Administration, Oral | 1 | 1995 | 3914 | 0.000 |
Why?
|
Hematocrit | 1 | 1988 | 636 | 0.000 |
Why?
|
ROC Curve | 1 | 1994 | 3528 | 0.000 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 1986 | 56 | 0.000 |
Why?
|
Macrophages | 2 | 1995 | 5660 | 0.000 |
Why?
|
Colony-Forming Units Assay | 1 | 1986 | 356 | 0.000 |
Why?
|
Punctures | 1 | 1988 | 374 | 0.000 |
Why?
|
Middle Aged | 2 | 2017 | 213390 | 0.000 |
Why?
|
Kell Blood-Group System | 1 | 1985 | 22 | 0.000 |
Why?
|
Monocytes | 1 | 1995 | 2596 | 0.000 |
Why?
|
Embryonic and Fetal Development | 1 | 1987 | 438 | 0.000 |
Why?
|
Fentanyl | 1 | 1989 | 409 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1985 | 419 | 0.000 |
Why?
|
Isoflurane | 1 | 1989 | 380 | 0.000 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1993 | 1821 | 0.000 |
Why?
|
Hemoglobin A | 1 | 1985 | 87 | 0.000 |
Why?
|
C-Peptide | 1 | 1986 | 419 | 0.000 |
Why?
|
Antigens, CD | 1 | 1995 | 4026 | 0.000 |
Why?
|
Pedigree | 1 | 1993 | 4642 | 0.000 |
Why?
|
Diseases in Twins | 1 | 1986 | 449 | 0.000 |
Why?
|
Sheep | 1 | 1987 | 1437 | 0.000 |
Why?
|
Disease Progression | 1 | 1999 | 13286 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11366 | 0.000 |
Why?
|
Spinal Neoplasms | 1 | 1989 | 760 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1993 | 3177 | 0.000 |
Why?
|
Hemoglobins | 1 | 1987 | 1532 | 0.000 |
Why?
|
Genetic Markers | 1 | 1988 | 2634 | 0.000 |
Why?
|
Fetal Growth Retardation | 1 | 1985 | 570 | 0.000 |
Why?
|
Cells, Cultured | 2 | 1987 | 19233 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1994 | 12244 | 0.000 |
Why?
|
Erythropoietin | 1 | 1985 | 726 | 0.000 |
Why?
|
Abdomen | 1 | 1986 | 1118 | 0.000 |
Why?
|
Kinetics | 1 | 1987 | 6476 | 0.000 |
Why?
|
Femur | 1 | 1986 | 1297 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 35425 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1986 | 1359 | 0.000 |
Why?
|
Follow-Up Studies | 2 | 1993 | 39052 | 0.000 |
Why?
|
Cell Division | 1 | 1986 | 4569 | 0.000 |
Why?
|
Blood Pressure | 1 | 1994 | 8551 | 0.000 |
Why?
|
Gene Expression Regulation | 2 | 1988 | 12073 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1995 | 10183 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1994 | 21748 | 0.000 |
Why?
|
Mutation | 1 | 1999 | 29786 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1986 | 20130 | 0.000 |
Why?
|